Diabetes care

Our journey in diabetes began over 90 years ago and since then, Novo Nordisk has been changing diabetes through innovation, education and collaboration.

Read more

Haemostasis management

Treatment of haemophilia patients, both A and B, and patients with other coagulation factor deficiencies is normally based on replacement therapy, this is substitution of the missing clotting factor.

Read more

Growth hormone therapy

Novo Nordisk is dedicated to furthering research into growth disorders and their treatment. We provide numerous services to help patients undergoing growth hormone treatment to live life to the full.  

Read more

Hormone replacement therapy

Treatments of menopausal symptoms tailored for the individual needs of women.

Read more


Obesity and weight management

Novo Nordisk is using its knowledge of protein chemistry, understanding of hormones and disease insight to develop efficient treatments for people with obesity.

Read more


UK19DI00394 December 2019